Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare industry. This time, you get to discover 5 hand-picked startups developing Point-of-Care Diagnostics solutions.
Global Startup Heat Map: 5 Top Point-of-Care Diagnostics Startups
The 5 startups you will explore below are chosen based on our data-driven startup scouting approach, taking into account factors such as location, founding year, and relevance of technology, among others. This analysis is based on the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering over 1.3 million startups & scaleups globally.
The Global Startup Heat Map below highlights the 5 Point-of-Care Diagnostics startups & scaleups our Innovation Researchers curated for this report. Moreover, you get insights into regions that observe a high startup activity and the global geographic distribution of the 162 companies we analyzed for this specific topic.
Click to download
Hememics develops PoC Solutions for Infectious Diseases
Advances in Point-of-Care diagnostics come from the development of technologies such as biosensors, microfluidics, and lab-on-chips. The main benefit of PoC diagnostics is that they facilitate low cost and rapid diagnostics without requiring the extensive sample treatment processes used by laboratories. Additionally, the coronavirus pandemic has shifted global research and development of PoC diagnostics due to their benefits with significant investments towards startups creating these solutions.
The US-based startup Hememics develops a point of care platform to rapidly identify infectious disease pathogens. The platform uses a single nasal swab or a drop of blood to test and measure specific antibody and antigen signals. The entire testing process takes under 60 seconds, tests for up to 17 different pathogens, and provides real-time diagnostics to healthcare workers and alerts for health agencies.
iFirst Medical Technologies provides Mobile Healthcare Diagnostics
Point-of-Care diagnostic solutions are not able to minimize their products’ cost as they require hardware to analyze the material and hardware to handle the processing. Startups utilize the abundant mobile phone market to develop PoC diagnostic solutions that use phone hardware for diagnostics which creates a more affordable self-diagnostic healthcare ecosystem.
Singaporean startup iFirst Medical Technologies develops a point of care diagnostic device that integrates with iOS. The device uses a cartridge system to analyze samples. The cartridges are available with pre-treated reagents for the analysis of different health parameters and biomarkers. The app then tracks a user’s coagulation profile in real-time and shares it over the cloud, wifi, or cellular data for a professional consultation.
Bialoom creates Biosensors for PoC
The diagnosis of cardiac-related illnesses and diseases, fertility, etc. is possible due to biochips that react to the substances contained in the sample. Biochip and biosensor manufacturers are creating more efficient manufacturing methods as they find use in healthcare applications such as wearables and Point-of-Care. Startups are also developing advanced biochips that detect a broader range of biomarkers and parameters for a range of health diagnostics.
Cyprus-based startup Bioloom develops high sensitivity biochips using proprietary plasmonic interferometric sensors. The micrometer-scale biosensor requires only minor traces of liquid on the sensing area to run tests. The startup is currently developing biochips for the diagnosis of anaphylaxis and sepsis.
Biosensorix works on Low-Cost Biomarker Detection
Point-of-care testing focuses on the use of biosensors and advanced lab-on-chip systems to run lab equivalent tests and determine results. Point-of-Care testing aims to be rapid while being effective and affordable to the mass market which is difficult with lab-on-chip-based testing devices. Startups are developing solutions for which only simple diagnostic results are required and that can be performed using an immunoassay.
Singaporean startup Biosensorix focuses on the development of low-cost and effective point of care solutions. The startup’s immune assay-based platform, ELLI, detects biomarkers and pathogens. Two more solutions include StackPad which is a laboratory-grade rapid and low-cost multiplex biomarker and pathogen detector and BioPen which uses fiber-optic biosensors for detection of DNA, RNA, antibodies, antigens, and biotoxicity.
Docturnal enables Non-Invasive Disease Detection
According to the WHO, an estimated 1.4 million people died from tuberculosis (TB) in 2019. Currently, TB is a challenging disease to treat due to factors such as the duration of treatment, negative reaction to anti-TB drugs, and the drug resistance of TB strains. The development of point of care diagnostics helps patients to proactively diagnose their health condition, which increases early TB detection and the subsequent early treatment.
Indian startup Docturnal specializes in the development of a non-invasive point of care diagnostic solution. The low cost and non-invasive solution uses AI and deep learning for early and proactive detection of TB biomarkers and symptoms. Their TB screening app TimBre uses recorded sounds of a patient’s cough and diagnoses the audio data along with demographic, clinical, and socioeconomic variables to determine if the patient is TB positive or negative. Doctunal’s solutions aim to solve the challenges of accessible and affordable tuberculosis care in developing countries.
Discover more Healthcare Startups
To keep you up-to-date on the latest technology and emerging solutions, we provide you with actionable innovation intelligence – quickly and exhaustively. You can download our free Healthcare Innovation Report and discover new business opportunities or save your time & let us look into your areas of interest. We provide you with an exhaustive overview of new startups, scaleups & emerging technologies that matter to you.
